Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Tumor necrosis factor receptor superfamily member 5 agonist | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 2 | D008545 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297718 |
CONTENTS